BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1033 related articles for article (PubMed ID: 8535213)

  • 1. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
    Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
    Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary cerebral non-Hodgkin's lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the registry of non-Hodgkin's lymphoma in western Denmark, LYFO and the cancer registry, Kraeftens Bekaempelse].
    Jensen MK; d'Amore FA; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Ugeskr Laeger; 1996 Jul; 158(31):4406-12. PubMed ID: 8759999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.
    d'Amore F; Brincker H; Grønbaek K; Thorling K; Pedersen M; Jensen MK; Andersen E; Pedersen NT; Mortensen LS
    J Clin Oncol; 1994 Aug; 12(8):1673-84. PubMed ID: 8040680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, presenting features and prognosis of low-grade B-cell non-Hodgkin's lymphomas. Population-based data from a Danish lymphoma registry.
    D'Amore F; Christensen BE; Thorling K; Pedersen M; Jensen MK; Boesen AM; Andersen E; Johansen P; Mortensen LS
    Leuk Lymphoma; 1993 Dec; 12(1-2):69-77. PubMed ID: 8161937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group.
    d'Amore F; Christensen BE; Brincker H; Pedersen NT; Thorling K; Hastrup J; Pedersen M; Jensen MK; Johansen P; Andersen E
    Eur J Cancer; 1991; 27(10):1201-8. PubMed ID: 1835586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975 to 1996.
    Hao D; DiFrancesco LM; Brasher PM; deMetz C; Fulton DS; DeAngelis LM; Forsyth PA
    Ann Oncol; 1999 Jan; 10(1):65-70. PubMed ID: 10076724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.
    Hayakawa T; Takakura K; Abe H; Yoshimoto T; Tanaka R; Sugita K; Kikuchi H; Uozumi T; Hori T; Fukui H
    J Neurooncol; 1994; 19(3):197-215. PubMed ID: 7807171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden.
    Samuelsson BO; Ridell B; Röckert L; Gustafsson G; Márky I
    J Pediatr Hematol Oncol; 1999; 21(2):103-10. PubMed ID: 10206455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary central nervous system lymphomas--an update.
    Jellinger KA; Paulus W
    J Cancer Res Clin Oncol; 1992; 119(1):7-27. PubMed ID: 1400570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
    van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
    Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
    Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
    Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group.
    Coté TR; Biggar RJ; Rosenberg PS; Devesa SS; Percy C; Yellin FJ; Lemp G; Hardy C; Geodert JJ; Blattner WA
    Int J Cancer; 1997 Nov; 73(5):645-50. PubMed ID: 9398040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study.
    Li J; Tang X; Luo X; Liu L; Li D; Yang L
    Ann Hematol; 2023 Aug; 102(8):2153-2163. PubMed ID: 37289220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway.
    Salvesen Haldorsen I; Aarseth JH; Hollender A; Larsen JL; Espeland A; Mella O
    Acta Oncol; 2004; 43(6):520-9. PubMed ID: 15370608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing incidence of non-Hodgkin's lymphoma in Karachi, 1995-2002.
    Bhurgri Y; Pervez S; Bhurgri A; Faridi N; Usman A; Kazi LA; Ahmed R; Kayani N; Hasan SH
    Asian Pac J Cancer Prev; 2005; 6(3):364-9. PubMed ID: 16236001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the therapy of primary central nervous system lymphoma.
    Plotkin SR; Batchelor TT
    Clin Lymphoma; 2001 Mar; 1(4):263-75; discussion 276-7. PubMed ID: 11707839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.